Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor Burden
Clinical trial NCT07715396 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07715396
- Sponsor
- AIO-Studien-gGmbH
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-30
- Primary completion
- 2031-10-30
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.